Skip to main content

Digital Pathology Market 2021, Size, Share, Growth, Trends, Revenue, Competitive Landscape, Demand, Forecast Report 2021-2028

Written by Customer Service on . Posted in Mergers And Acquisitions.

Pune, India, Feb. 16, 2021 (GLOBE NEWSWIRE) — The Global Digital Pathology Market is likely to expand due to the rising use of advanced diagnostic tools for prompt diagnosis of chronic diseases. According to a report, titled “Digital Pathology: Global Market Analysis, Insights and Forecast, 2018-2025,” the market is likely to grow due to the increasing number of people diagnosed with related diseases.The Market is likely to grow in the forthcoming years due to recent technological advancements in pathology devices. Recent advancements have induced increasing operational efficacy, which is a major factor propelling growth in the global digital pathology market
Sample PDF Brochure of Digital Pathology Market: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/digital-pathology-market-100229
A hospital, research laboratory and any related center can transfer the image anywhere in the world within no time. This significantly reduces the time to treat and diagnose and eliminates the need to call upon a specialist for a consultation. The aforementioned factors have created an increasing adoption of digital pathology over other methods.Use of Digital Pathology in Surgical Procedures Has Proven Hugely BeneficialIn surgical pathology, the diagnosed tissue can be detected, diagnosed, treated, and then incised into paper thin slices. These slices are then mounted upon glass slides, which are then examined by pathologists under microscopic conditions. This method was a first of its kind and possesses very high efficiency, besides offering clear and sharp images.Furthermore, digital slides can be reproduced as many times as needed. Therefore, the use of pathology in surgical procedures ensures higher surgical efficiency and reduces the time required for diagnosis and operation. This has led to rapid adoption of digital pathology around the world.
For more information visit: https://www.fortunebusinessinsights.com/industry-reports/digital-pathology-market-100229
FDA Clearance for Philips’ Intellisite Pathology to Bode Well for Digital Pathology MarketIn April 2017, the FDA gave its approval to Philips’ Intellisite Pathology (PIPS) for manufacturing and sale in the U.S. This was the first ever digital pathology system in the market with FDA clearance. According to Fortune Business Insights, approval to Philips’ Intellisite will encourage other pathology device manufacturers to come up with their own patents and use PIPS as a reference.Secondly, pathologists and related clinical centers that had held off buying any type of pathology systems, until they would receive clearance from a regulatory authority, would now willingly invest and buy Philips’ Intellisite due to the FDA approval. Such factors will lead to the entry of newer market players and also encourage existing companies to improvise as well as improve their product to shake off competition from Philips.
Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/digital-pathology-market-100229
Key Players Covered in the Digital Pathology Market Report:3DHISTECH – The Digital Pathology CompanyMikroscan Technologies, Inc.Objective Pathology ServicesHamamatsu PhotonicsRoche Diagnostics DanmarkPrimera TechnologyBiogenuix Medsystems Pvt LtdIndica LabsPhilips BeneluxInspirataLigoLab LLCLeica BiosystemOlympus Corporation of the AmericasNikon Optical Canada Inc.
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/queries/digital-pathology-market-100229
Key Segmentations:by TechnologyWhole Slide ImagingImage Analytics InformationDigital CytopathologyDigital HolographyMicroscopyby ApplicationHematology AnalysisBlood Cell CountingUrine Sediment AnalysisDisease Diagnosisby End UserPathology LaboratoriesHospitalsPharmaceutical and Biotechnology CompaniesDiagnostic Centersby GeographyNorth AmericaEuropeAsia PacificLatin AmericaMiddle East & Africa
Have a Look at Related Reports:Thrombin Market Share and Global Trend By Product (Bovine Thrombin, Human Thrombin, Recombinant Thrombin), By Dosage Form (Powder Form, Solution Form), By End user (Hospitals, Diagnostics Centers & Clinics, Academics and Research Institutes), and Geography Forecast till 2025Dialyzers Market Growth, Size, Share and Global Trend by Flux Type (High-flux, Low-Flux), By Usage Type (Disposable, Reusable), By End User (Dialysis Centers and Hospitals, Home Healthcare), and Geography Forecast till 2026Hemostats Market Segments, Size, Share and Global Trend By Product Type (Active Hemostats, Passive Hemostats, Combination Hemostats), Application (Trauma, Cardiovascular Surgery, General Surgery, Plastic Surgery, Orthopedic Surgery & Neurosurgery), End User (Hospitals, Ambulatory Surgical Centers, Tactical Combat Casualty Care Centers) and Geography Forecast till 2025Contraceptive Drugs Market Size, Share and Global Trend By Product Type (Oral, Injectable, Patches), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channel, Public Channel & NGOs) and Geography Forecast till 2025
About Us:Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.